LPLéa Pinon

Léa Pinon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Léa Pinon has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protocol for Rapid Drug Profiling of Patient-Derived Tumor-On-Chip Models

    by Léa Pinon, Clara Helal, Ana Vazquez, Juliette Jin, Léna Domalain, Niccolo Schintu, Maxime Simon, Maria Carla Parrini, Stephanie Descroix

    Rapid drug sensitivity profiling from limited numbers of cancer cells remains challenging with the current models. Here, we present a Tumor-on-Chip protocol optimized for functional drug sensitivity profiling within 4 days, including a custom chip requiring minimal biopsy material. We describe tissue dissociation, tumor cell isolation, chip preparation, drug exposure, image acquisition, and data analysis for PDX-derived tumors, surgical resections, and biopsies. The protocol enables discrimination of drug-sensitive and resistant tumor profiles and provides a platform for patient-specific treatment testing.For complete details on the use and execution of this protocol, please refer to Helal et al.1

  • Open Access

    Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer

    by Clara Helal, Léa Pinon, Juliette Jin, Niccolo Schintu, Ana Vazquez, Léna Domalain, Martin Nurmik, Gianni Antonelli, Ségolène Ladaigue, Maxime Simon, et al.


  • Emulsion droplets and microfluidic traps to study the B cells polarization and its mechanics

    by Léa Pinon

    Gouttes d’émulsions et pièges microfluidiques pour l’étude de la polarisation et des mécanismes des lymphocytes B: Juste après l'invasion d'un agent pathogène, un organisme déploie deux lignes de défense : l'immunité innée et l'immunité adaptative. La première est une réponse à court terme qui prévoit la destruction de l'agent pathogène puis la présentation de l'antigène par des cellules présentatrices d'antigènes (CPA). La dernière assure une importante réponse à long terme principalement grâce aux lymphocytes B qui sécrètent des anticorps à haute affinité et se différencient en lymphocytes B mémoires. Pour ce faire, les cellules B capturent soient des petits antigènes solubles (< 70 kDa) ou extraient les plus volumineux (> 70 kDa) sur différentes CPA telles que les macrophages, les cellules dendritiques et les cellules dendritiques folliculaires. Dans le dernier cas, les CPA et les lymphocytes B assurent le transfert d'antigènes via un contact hautement organisé : la synapse immunologique. Pour comprendre précisément les mécanismes physico-chimiques impliqués dans cette synapse, nous avons d'abord modélisé le contact APC-lymphocyte par nouveau substrat imitant les propriétés membranaires des CPA, et respectant des caractéristiques cruciales telles que la concentration d'antigènes, la mobilité et la déformabilité de la surface. Les gouttes de l'émulsion huile dans eau imitent correctement la mobilité des antigènes à l'interface huile/eau telle qu'elle est observée sur la membrane cellulaire ; et en raison d'une tension superficielle faible et contrôlable, les gouttes sont aussi déformables qu'un véritable APC. Nous avons également utilisé des dispositifs de piégeage microfluidiques pour faciliter l'observation de plusieurs synapses isolées simultanément et suivre leur formation dans le temps. Par conséquent, nous contrôlons temporellement et spatialement la synapse de entre la goutte de type APC et le lymphocyte B. En combinant ces outils, gouttes et pièges microfluidiques, nous avons quantifié la cinétique des lysosomes au cours du temps. En se déplaçant vers la zone de la synapse, ils participent à la polarisation des lymphocytes. Nous avons donc choisi de suivre ces lysosomes afin de quantifier la polarisation cellulaire. Nous avons analysé à la fois le déclenchement de la polarisation et sa cinétique lorsque les cellules B interagissent avec différentes conditions de gouttes. Nous démontrons que (i) les événements de polarisation sont déclenchés lorsque plus de 75 antigènes/µm2 sont impliqués au niveau de la synapse, (ii) la mobilité des antigènes ne contribue à déclencher de tels événements que lorsque les antigènes viennent à manquer (< 75 antigens/µm2), et (iii) les rigidités élevées des gouttes déclenchent la polarisation et modulent leur cinétique. Nous observons également des événements d’anti-polarisation, c'est-à-dire que les lysosomes se déplacent vers l'arrière des cellules, dont la cinétique ne dépend que de la rigidité ; cependant, leur déclenchement dépend à la fois de la concentration et de la mobilité des antigènes. En conclusion, ces résultats apportent clairement une quantification des propriétés de la membrane APC affectant le comportement des lymphocytes B lors de la formation de la synapse immune. En outre, dans quelques résultats préliminaires nous avons quantifié la force appliquée par les cellules B sur les gouttes les plus déformables. Nous découvrons que celles-ci sont en effet déformées par les lymphocytes B lors de la formation de la synapse. De tels résultats prouvent que les gouttelettes que nous avons formulées sont des outils prometteurs pour mesurer dynamiquement la force cellulaire appliquée par les cellules immunitaires non cytotoxiques ou non phagocytaires comme le sont les lymphocytes B. Nous avons déterminé le module viscoélastique des gouttes et des lymphocytes B grâce à des expériences sur microplaques de verre. Premièrement, nous avons confirmé que les cellules B sont 3 fois à 9 fois plus souples que respectivement les cellules dendritiques et les macrophages, et sont donc confrontées

  • Open Access

    An in vitro human vessel model to study Neisseria meningitidis colonization and vascular damages

    by Léa Pinon, Melanie Chabaud, Pierre Nivoit, Jerome Wong Ng, Tri-Tho Nguyen, Vanessa Paul, Charlotte Bouquerel, Sylvie Goussard, Pauline Smilovici, Emmanuel Frachon, et al.

    The authors develop an important microfluidic microvascular model called "Vessel-on-Chip", which they use to study Neisseria meningitidis interactions within this in vitro vascular system. Compelling evidence shows that the fabricated channels are lined by endothelial cells, and these can be colonized by N. meningitidis that in turn triggers neutrophil recruitment. This model has advantages over the human skin xenograft mouse model, which requires complex surgical techniques, however, it also carries limitations in that only endothelial cells and supplied specific immune cells in the microfluidics are present, while true vasculature contains a number of other cell types including smooth muscle cells, pericytes, and components of the immune system.


  • Open Access

    An in vitro human vessel model to study Neisseria meningitidis colonization and vascular damages

    by Léa Pinon, Mélanie Chabaud, Pierre Nivoit, Jérôme Wong-Ng, Tri Tho Nguyen, Vanessa Paul, Charlotte Bouquerel, Sylvie Goussard, Pauline Smilovici, Emmanuel Frachon, et al.

    Systemic infections leading to sepsis are life-threatening conditions that remain difficult to treat, and the limitations of current experimental models hamper the development of innovative therapies. Animal models are constrained by species-specific differences, while 2D cell culture systems fail to capture the complex pathophysiology of infection. To overcome these limitations, we developed a laser photoablation-generated, three-dimensional microfluidic model of meningococcal vascular colonization, a human-specific bacterium that causes sepsis and meningitis. Laser photoablation-generated hydrogel engineering allows the reproduction of vascular networks that are major infection target sites, and this model provides the relevant microenvironment reproducing the physiological endothelial integrity and permeability in vitro. By comparing with a human-skin xenograft mouse model, we show that the model system not only replicates in vivo key features of the infection, but also enables quantitative assessment with a higher spatiotemporal resolution of bacterial microcolony growth, endothelial cytoskeleton rearrangement, vascular E-selectin expression, and neutrophil response upon infection. Our device thus provides a robust solution bridging the gap between animal and 2D cellular models, paving the way for a better understanding of disease progression and developing innovative therapeutics.


  • Open Access

    Tumor-on-Chip as a Personalised Platform for Rapid Drug-Testing in Breast Cancer

    by Clara Helal, Léa Pinon, Juliette Jin, Niccolo Schintu, Ana Vazquez, Martin Nurmik, Gianni Antonelli, Maxime Simon, Elodie Montaudon, Laura Sourd, et al.

    Breast cancer (BC) remains one of the most common malignancies worldwide and continues to pose major therapeutic challenges, emphasizing the need for functional models that can inform fast treatment selection. Currently, patient-derived xenografts (PDXs) and organoids (PDOs) are valuable biological models for functional precision oncology; however, variable success rates of establishment and prolonged timelines limit their clinical application for real-time drug testing. To overcome this, we developed a Tumor-on-Chip (ToC) platform that enables functional drug sensitivity profiling within a clinically actionable 4-day timeframe. We compared ToC models with PDX results, and demonstrated high reproducibility and strong concordance with in vivo PDX responses. Drug sensitivity was correctly identified ex vivo in 88% of PDX-responsive cases, while resistance was detected in 91%, with no false positives at clinically relevant drug concentrations. To facilitate clinical translation, we engineered a custom microfluidic chip optimized for minimal breast cancer biopsy material, yielding results similar to those obtained from resection samples. We ultimately demonstrated the proof-of-concept for applying this platform to patient samples as a further tool for guiding clinical decision-making and discriminated between resistance and sensitive profiles among patients. These findings demonstrate the feasibility and translational potential of ToC models for personalized drug profiling in breast cancer, laying the groundwork for their integration into real-time clinical decision-making workflows.

  • Open Access

    An in vitro human vessel model to study Neisseria meningitidis colonization and vascular damages

    by Léa Pinon, Mélanie Chabaud, Pierre Nivoit, Jérôme Wong-Ng, Tri Tho Nguyen, Vanessa Paul, Charlotte Bouquerel, Sylvie Goussard, Pauline Smilovici, Emmanuel Frachon, et al.

    Systemic infections leading to sepsis are life-threatening conditions that remain difficult to treat, and the limitations of current experimental models hamper the development of innovative therapies. Animal models are constrained by species-specific differences, while 2D cell culture systems fail to capture the complex pathophysiology of infection. To overcome these limitations, we developed a laser photoablation-generated, three-dimensional microfluidic model of meningococcal vascular colonization, a human-specific bacterium that causes sepsis and meningitis. Laser photoablation-generated hydrogel engineering allows the reproduction of vascular networks that are major infection target sites, and this model provides the relevant microenvironment reproducing the physiological endothelial integrity and permeability in vitro . By comparing with a human-skin xenograft mouse model, we show that the model system not only replicates in vivo key features of the infection, but also enables quantitative assessment with a higher spatiotemporal resolution of bacterial microcolony growth, endothelial cytoskeleton rearrangement, vascular E-selectin expression, and neutrophil response upon infection. Our device thus provides a robust solution bridging the gap between animal and 2D cellular models, paving the way for a better understanding of disease progression and developing innovative therapeutics.

  • Open Access

    Microtubules restrict F-actin polymerization to the immune synapse via GEF-H1 to maintain polarity in lymphocytes

    by Judith Pineau, Léa Pinon, Olivier Mesdjian, Jacques Fattaccioli, Ana-Maria Lennon Duménil, Paolo Pierobon

    Immune synapse formation is a key step for lymphocyte activation. In B lymphocytes, the immune synapse controls the production of high-affinity antibodies, thereby defining the efficiency of humoral immune responses. While the key roles played by both the actin and microtubule cytoskeletons in the formation and function of the immune synapse have become increasingly clear, how the different events involved in synapse formation are coordinated in space and time by actin-microtubule interactions is not understood. Using a microfluidic pairing device, we studied with unprecedented resolution the dynamics of the various events leading to immune synapse formation and maintenance. Our results identify two groups of events, local and global dominated by actin and microtubules dynamics, respectively. They further highlight an unexpected role for microtubules and the GEF-H1-RhoA axis in restricting F-actin polymerization at the immune synapse to define the cell polarity axis, allowing the formation and maintenance of a unique competent immune synapse.


  • Open Access

    Phenotyping Polarization Dynamics Of Immune Cells Using A Lipid Droplet - Cell Pairing Microfluidic Platform

    by Léa Pinon, Nicolas Ruyssen, Judith Pineau, Olivier Mesdjian, Damien Cuverlier, Anna Chipont, Rachele Allena, Coralie L. Guerin, Sophie Asnacios, Atef Asnacios, et al.

    The immune synapse is the tight contact zone between a lymphocyte and a cell presenting its cognate antigen. This structure serves as a signaling platform and entails a polarization of intra-cellular components, necessary to the immunological function of the cell. While the surface properties of the presenting cell are known to control the formation of the synapse, their impact on polarization has not yet been studied. Using functional lipid droplets as tunable artificial presenting cells combined with a microfluidic pairing device, we simultaneously observe synchronized synapses and dynamically quantify polarization patterns of individual B cells. By assessing how ligand concentration, surface fluidity and substrate rigidity impact lysosome polarization, we show that its onset and kinetics depend on the local antigen concentration at the synapse and on substrate rigidity. Our experimental system enables a fine phenotyping of monoclonal cell populations based on their synaptic readout.

  • Mannose-Coated Fluorescent Lipid Microparticles for Specific Cellular Targeting and Internalization via Glycoreceptor-Induced Phagocytosis

    by Blaise Dumat, Lorraine Montel, Léa Pinon, Pascal Matton, Laurent Cattiaux, Jacques Fattaccioli, Jean-Maurice Mallet

    In this work we report on the development of mannose-coated fluorescent lipid microparticles to study the role of C-type lectin membrane receptor in phagocytosis. The micrometric droplets of Soybean oil in water emulsion were functionalized with a tailor-made fluorescent mannolipid. The amphiphilic ligand was built from a mannose unit, a lipid C11 spacer and a naphthalimide fluorophore. The droplets functionalization was monitored by fluorescence microscopy as well as the interaction with concanavalin A which was used as a model lectin in vitro. The use of a monovalent ligand on the surface of emulsion droplets yielded particles with an affinity approximately 40 times higher than that of free mannose. In cellulo, the coated droplets were shown to be specifically internalized by macrophages in a receptor-dependent phagocytic pathway. The naked droplets on the other hand display very little internalization due to their low immunogenicity. This work thus brings evidence that C-type lectin membrane receptors may act as phagocytic receptors. The droplets functionalization with the tailored amphiphilic fluorescent ligand and the droplets functionalization also provides insights into the development of organic fluorescent particles that may prove useful for developing targeted imaging and delivery tools.